Brief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region
29/11/2018 24:20
Nov 29 (Reuters) - Seoul Pharma Co Ltd 018680.KQ :
* SEOUL PHARMA SAYS TERMINATES CONTRACT WORTH 5.9 BILLION
WON
($5.25 MILLION) TO SUPPLY ERECTILE DYSFUNCTION DRUGS IN MIDDLE
EAST REGION
* SEOUL PHARMA - SUPPLY DEAL CANCELLED AS ITS COUNTERPART
MEDVISION FOR MEDICAL SERVICES CLOSES DOWN MEDICAL DIVISION
Source text for Eikon: https://bit.ly/2SdMxnI
Further company coverage: 018680.KQ
($1 = 1,123.4000 won)
(Reporting by Joori Roh)
((joori.roh@thomsonreuters.com;))
Recent news on Seoul Pharma
See all newsBrief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region
Brief: Seoul Pharma appoints CEO
Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won
Brief: Seoul Pharma signs contract worth 7.86 bln won
Brief: Seoul Pharma signs contract worth 8.62 bln won